ZyVersa Therapeutics, Inc.
USD0.12
-0.01 (-4.17%)
CEO
Stephen C. Glover
IPO Date
2022-02-11
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.10
Prev. Close
$0.12
Day Low
$0.10
Day High
$0.12
52W Low
$0.10
52W High
$0.30
Market Cap
$0.00B
Volume
0.01M
| 11,066 |
| $0.59 |
| 15 Jul 2025 | Glover Stephen C. | director, officer: Chief Executive Officer | A-Award | Acquired | 136,900 | $0.59 |
| 15 Jul 2025 | Finizio Robert G | director | A-Award | Acquired | 11,066 | $0.59 |
| 15 Jul 2025 | Wolfe Peter | Chief Financial Officer | A-Award | Acquired | 60,100 | $0.59 |
| 15 Jul 2025 | Guzman Pablo A. | Chief Medical Officer | A-Award | Acquired | 48,900 | $0.59 |
| 15 Jul 2025 | Park Min-Chul | director | A-Award | Acquired | 11,066 | $0.59 |
| 15 Jul 2025 | SAPIRSTEIN JAMES | director | A-Award | Acquired | 11,066 | $0.59 |
| 18 Jul 2024 | Finizio Robert G | director | A-Award | Acquired | 132 | $152.46 |
| 18 Jul 2024 | Glover Stephen C. | director, officer: Chief Executive Officer | A-Award | Acquired | 1,627 | $152.46 |